Broader Economy Weighs Down LS Tools, MDx Stocks | GenomeWeb

NEW YORK (GenomeWeb) – A tumultuous global stock market weighed heavily on the shares of companies in the omics life science tools and molecular diagnostics space in August as the GenomeWeb Index fell nearly 8 percent month over month. 

The number of decliners outnumbered the number of gainers 25 to seven in August, and the index also fell more sharply than the Dow Jones Industrial Average and the Nasdaq Composite, both of which fell about 7 percent month over month. It beat the Nasdaq Biotechnology Index, however, which saw an 11 percent contraction in August. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.